Michigan

Michigan's life sciences ecosystem has evolved into a powerhouse of biotechnology and pharmaceutical manufacturing, currently ranking as a top-ten national cluster with a total economic impact exceeding $55 billion.

The state is globally recognized as a premier hub for medical device manufacturing, anchored by industry giants like Stryker and Terumo, and supported by a robust supply chain of over 500 specialized firms.

Michigan's "University Research Corridor," featuring the University of Michigan, Michigan State University, and Wayne State University, drives world-class academic research and clinical translation, consistently securing annual NIH funding.

Innovation flourishes through strategic public-private partnerships, such as the Henry Ford + MSU Innovation Hub, which accelerates healthcare innovation by bridging the gap between bench science and bedside care.

The state's specialized workforce of nearly 50,000 professionals excels in precision medicine, biopharmaceutics and digital health solutions.

In Ann Arbor and Grand Rapids, a burgeoning startup culture is fueled by significant venture capital investment and a massive academic therapeutic pipeline.

As a leader in contract manufacturing (CMO) and clinical trial design, Michigan offers a competitive advantage for global firms seeking scalable, high-tech production environments.

From breakthrough orthopedic technologies to advanced bio-analytics, Michigan's integrated ecosystem continues to redefine the frontiers of global health.